Low-dose conbercept for retinopathy of prematurity
Part of Eyes & vision, Genetic & congenital clinical trials.
This trial tests whether a low dose of conbercept, given as an eye injection, can safely treat type 1 ROP (an eye disease in premature babies). The goal is to stop abnormal blood vessel growth and prevent vision loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born prematurely, weighing at most 2000 grams (4 lb 6 oz) or before 32 weeks of pregnancy.
- Your baby has a specific form of ROP (type 1) in both eyes, as confirmed by an eye exam.
- Your baby has not received any prior ROP treatment such as laser, anti-VEGF injections, or eye surgery.
- Your baby (or you, during pregnancy) has not received any anti-VEGF medication before.
- Your baby does not have an active eye infection or any other medical condition that would make the treatment unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the tiny blood vessels in the back of the eye (retina) of premature infants who are at risk for retinopathy of prematurity, a condition that can harm vision. It aims to improve care and monitoring by using advanced eye imaging to see more detail than current methods.
This study tests a new eye imaging device to check for retinopathy of prematurity (ROP), a condition that can affect vision in premature babies. It may help doctors diagnose ROP earlier and more easily at the bedside.
This study looks at how laser or injection treatments for retinopathy of prematurity (ROP) affect vision and eye health later in life. It also includes children who had ROP but did not need treatment.
This study tests two drug-free methods to help reduce pain when premature babies get a special eye exam for retinopathy of prematurity. It may help your baby feel more comfortable during the procedure.
This trial tests whether giving propranolol by mouth to certain very premature babies with early eye changes can stop retinopathy of prematurity from getting worse. It may help reduce the need for eye treatments later on.
This study uses pictures to map the tiny blood vessels in an infant’s retina (the back of the eye). It may help researchers better understand how eye blood vessel growth happens in premature babies who need screening for ROP (retinopathy of prematurity).
Hear when a new Retinopathy of Prematurity (ROP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.